亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

木犀草素-5-O-葡萄糖苷 CAS:20344-46-1

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 四川成都市付款后3天內(nèi)
品牌 鈉鈳鋰
過(guò)期 長(zhǎng)期有效
更新 2021-11-25 12:22
 

成都鈉鈳鋰生物科技有限公司

企業(yè)會(huì)員第5年
資料未認(rèn)證
保證金未繳納
詳細(xì)說(shuō)明

nkl-00093

中文名稱:木犀草素-5-O-葡萄糖苷
中文別名:藤黃菌素
英文名稱:Luteolin 5-glucoside
英文別稱:Galuteolin; Luteolin 5-O-β-D-glucopyranoside; Luteolin 5-glucoside; Luteolin 5-β-D-glucopyranoside; Luteolin-5-O-glucoside;Luteolin-5-O-β-D-glucoside
CAS號(hào):20344-46-1
純度: HPLC≥98%

分子式:C21H20O11
分子量:448.38
外觀:黃色粉末
溶點(diǎn):260 - 263°C
沸點(diǎn):864.2±65.0°C
密度:1.713±0.06克/立方厘米|條件:溫度:20°C
PKA:6.42±0.40 |條件:酸性最強(qiáng)溫度:25°C
提取來(lái)源:雞肝散
藥理藥效:保護(hù)心肌缺血,抗心肌缺血性心肌失常。

規(guī)格:10mg,20mg,50mg;可根據(jù)客戶需求包裝、定制

儲(chǔ)存條件: 低溫,避光、干燥、密封

用途: 用于鑒別、含量測(cè)定、藥理實(shí)驗(yàn)、活性篩選等科研、實(shí)驗(yàn)室使用;不得直接用于人體

供應(yīng)商:成都鈉鈳鋰生物科技有限公司

舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
2”-O-沒(méi)食子酰基金絲桃苷 CAS:53209-27-1 甘草酸 CAS:1405-86-3 甘草酸銨 CAS:53956-04-0 甘草查爾酮A CAS:58749-22-7 甘草查爾酮B CAS:58749-23-8 甘草查爾酮C CAS:144506-14-9 重樓皂苷II CAS:50773-42-7 重樓皂苷III CAS:19057-60-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |